Who is sponsoring NCT03219125?

NCT03219125 is sponsored by University Hospital, Lille.

What drugs are being tested in NCT03219125?

Interventions in NCT03219125: Dixon Magnetic Resonance Imaging, dual-energy X-ray absorptiometry (DXA).

What condition does NCT03219125 study?

NCT03219125 studies Fractures, Bone, Bone Marrow Disease, Fat Disorder, Adiposity.

Is NCT03219125 still recruiting?

NCT03219125 is currently completed. Last updated 4 November 2022.

Last reviewed 2022-11-04 · How we verify

NCT03219125: ADIMOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women

Completed Last updated 4 November 2022

What this trial tests

trial testing Dixon Magnetic Resonance Imaging in Fractures, Bone in 203 participants. Completed in 25 June 2021.

Timeline

16 October 2018

Primary endpoint
25 June 2021

25 June 2021

Quick facts

Lead sponsor	University Hospital, Lille
Status	Completed
Study type	OBSERVATIONAL
Enrollment	203
Start date	16 October 2018
Primary completion	25 June 2021
Estimated completion	25 June 2021
Sites	1 location across France

Drugs / interventions tested

Dixon Magnetic Resonance Imaging
dual-energy X-ray absorptiometry (DXA)

Conditions studied

Fractures, Bone — all drugs for Fractures, Bone →
Bone Marrow Disease — all drugs for Bone Marrow Disease →
Fat Disorder — all drugs for Fat Disorder →
Adiposity — all drugs for Adiposity →

Sponsor

University Hospital, Lille

Who can join

Adults 50 to 90, female only, with Fractures, Bone or Bone Marrow Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose is to determine in a case-control study if an association exist between bone marrow adiposity and fragility fractures in post-menopausal women.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific.
Badr S, Cotten A, Lombardo D, Ruschke S, et al · · 2024 · cited 4× · PMID 39381685 · DOI 10.1210/jendso/bvae161
Marrow Adiposity Content and Composition Are Not Associated With Incident Fragility Fractures in Postmenopausal Women: The ADIMOS Fracture Study.
Philippoteaux C, Badr S, Lombardo D, Cailliau E, et al · · 2025 · cited 1× · PMID 40071067 · DOI 10.1210/jendso/bvaf033
Relationship between bone marrow adipose tissue and kidney function in postmenopausal women.
Badr S, Cotten A, Mentaverri R, Lombardo D, et al · · 2023 · cited 1× · PMID 37711545 · DOI 10.1016/j.bonr.2023.101713
Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures.
Badr S, Dapvril H, Lombardo D, Khizindar H, et al · · 2023 · PMID 37404309 · DOI 10.3389/fendo.2023.1178464

Verify or expand the search:

Other recruiting trials for Fractures, Bone

Currently open trials in the same condition.

NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
NCT06113211 — Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures · Phase 4 · recruiting
NCT06013852 — Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospectiv · NA · recruiting
NCT06256458 — Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma · recruiting

Other University Hospital, Lille trials

Trials by the same sponsor.

NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03219125 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
Last refreshed: 4 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03219125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing